Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$1.31 - $2.14 $2.97 Million - $4.86 Million
-2,270,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$1.85 - $3.04 $4.2 Million - $6.9 Million
2,270,000 New
2,270,000 $4.47 Million

Others Institutions Holding HOTH

About Hoth Therapeutics, Inc.


  • Ticker HOTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,288,470
  • Market Cap $1.11M
  • Description
  • Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...
More about HOTH
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.